Aquarius Surgical Technologies Inc.
AQQRF
$0.0042
$0.000.00%
| Weiss Ratings | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.11 | |||
| Price History | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | -79.00% | |||
| 3-Year Total Return | -28.81% | |||
| 5-Year Total Return | -98.36% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 13, 2025 | |||
| 52-Week High Price (Date) | Mar 13, 2025 | |||
| Valuation | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 383.75K | |||
| Enterprise Value | 3.53M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | 39.53% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.45 | |||
| Price/Book (Q) | -0.03 | |||
| Enterprise Value/Revenue (TTM) | 36.40 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -6.88 | |||
| Enterprise Value/EBIT | -6.68 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 27.60M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 877 740 2784 | |||
| Address | 89 Scollard Street Toronto, ON M5R 1G4 | |||
| Website | aquariussurgical.com | |||
| Country | Canada | |||
| Year Founded | 1986 | |||
| Profitability | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -544.54% | |||
| Profit Margin | -818.85% | |||
| Management Effectiveness | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -68.01% | |||
| Return on Equity | -- | |||
| Income Statement | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 80.60K | |||
| Total Revenue (TTM) | 80.60K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 41.50K | |||
| EBITDA (TTM) | -426.70K | |||
| EBIT (TTM) | -438.90K | |||
| Net Income (TTM) | -660.00K | |||
| Net Income Avl. to Common (TTM) | -660.00K | |||
| Total Revenue Growth (Q YOY) | -77.18% | |||
| Earnings Growth (Q YOY) | -27.98% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | -28.57% | |||
| Balance Sheet | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.70K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 65.70K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -3.68M | |||
| Current Ratio (Q) | 0.055 | |||
| Book Value Per Share (Q) | -$0.13 | |||
| Total Assets (Q) | 329.00K | |||
| Total Current Liabilities (Q) | 1.19M | |||
| Total Debt (Q) | 3.15M | |||
| Total Liabilities (Q) | 4.01M | |||
| Total Common Equity (Q) | -3.68M | |||
| Cash Flow | AQQRF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 0.00 | |||
| Cash from Financing (TTM) | 183.60K | |||
| Net Change in Cash (TTM) | -98.10K | |||
| Levered Free Cash Flow (TTM) | -289.50K | |||
| Cash from Operations (TTM) | -281.60K | |||
